Low-Dose Naltrexone Falls Short for Fibromyalgia

Despite off-label use of naltrexone by some patients with fibromyalgia in clinical practice, data from a randomized trial showed no pain relief advantage with the drug over placebo.

Related Keywords

Germany ,Odense ,Syddanmark ,Denmark ,Montreal ,Quebec ,Canada ,Mary Ann Fitzcharles ,Odense University Hospital ,Mental Health ,Mcgill University Health Centre ,Fibromyalgia Impact Questionnaire Revised ,Pain Medicine ,Karin Due Bruun ,Lancet Rheumatology ,Fibromyalgia ,Spain ,Pain Management ,Memory Problems ,Hospitals ,Memory ,Off Label Indication ,Patient Safety ,Adverse Effects ,Side Effects ,Anxiety ,Fatigue ,Sleep ,Anxiety Disorder ,Depression ,Sleep Disturbance ,Bnormal Sleep Pattern ,Sleep Disorder ,Omnipathy ,